Large study finds no link between acetaminophen use in pregnancy and neurodevelopmental disorders. Get the details
Study Finds No Link Between Acetaminophen Use During Pregnancy and
Neurodevelopmental Disorders in Children
A recent study published in the journal JAMA suggests that using
acetaminophen, the active ingredient in Tylenol, during pregnancy does not
increase the risk of autism, ADHD, or intellectual disability in children.
The study, which examined the prenatal and medical records of
approximately 2.5 million children born in Sweden between 1995 and 2019,
utilized a statistical model to compare children exposed to acetaminophen
during pregnancy with those who were not. While the initial analysis indicated
a marginal increase in the risk of neurodevelopmental disorders among the
exposed group, a sibling analysis — comparing outcomes among full sibling pairs
with the same biological parents — found no evidence of such associations.
Sibling analyses are particularly robust as they control for shared
genetic and environmental factors, providing more accurate insights compared to
traditional clinical trials. Dr. Eric Brenner, an assistant professor at Duke
University, commended the study's large sample size and sibling analysis,
emphasizing its strength in dispelling concerns about acetaminophen use during
pregnancy.
Contrary to recent research and statements suggesting a link between
acetaminophen use during pregnancy and neurodevelopmental disorders, including
autism and ADHD, this study challenges such assertions. The authors attribute
previous associations to confounding factors, such as parents' underlying
health conditions and sociodemographic characteristics, rather than the direct
effects of acetaminophen.
While acetaminophen is generally considered safe during pregnancy by
regulatory agencies like the FDA and the European Medicines Agency, cautionary
recommendations have emerged from some quarters. However, the findings of this
study provide reassurance regarding the safety of acetaminophen use during
pregnancy, particularly for managing fever and pain.
Dr. Yalda Afshar, from UCLA, advises pregnant individuals to consult
healthcare professionals regarding medication use during pregnancy. Overall,
this study underscores the importance of evidence-based decision-making and
informed discussions between patients and healthcare providers to optimize
maternal and fetal health.
COMMENTS